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Jan D. Schmitto, MD‡, and John M. Stulak, MD§Minimally invasive and alternative surgical techniques for long-term contemporary left
ventricular assist devices (LVAD) placement are feasible, and we believe such strategies
allow the development of novel and less traumatic surgical options for advanced heart
failure patients undergoing continuous-ﬂow (CF) LVAD implantation. These approaches
also promise the possibility of increasing the number of high-risk surgical patients who
could beneﬁt from CFLVAD therapies. This manuscript presents details a variety of surgical
strategies using less invasive and alternative strategies for long-term LVAD implants.
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Left ventricular assist device (LVAD) therapy is an effectivestrategy to bridge patients with end-stage decompen-
sated heart failure (HF) to orthotopic heart transplantation.1
Advances in LVAD pump technology from bulky pulsatile
devices to smaller continuous-ﬂow (CF) pumps, combined
with a better understanding of patient management, have led
to progressive improvements in long-term outcomes and
pump durability after implantation.2,3 Mechanical circulatoryee front matter r 2014 Elsevier Inc. All rights reserved.
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ashville, TN 37232-8808. E-mail: simon.maltais@support using the centrifugal CF HeartWare ventricular assist
device (HVAD; HeartWare International, Inc, Framingham,
MA) and the axial CF HeartMate-II LVAD (HM-II, Thoratec,
Pleasanton, CA) are the 2 most commonly implanted pumps
in the contemporary era. Radical differences in pump design
and standard implantation techniques between HVAD and
HM-II LVADs have initiated the quest for pioneering surgical
approaches focusing on the development of alternative and less
invasive implantation techniques.4-9
Several newer surgical approaches have been described for
HVAD and HM-II CF-LVAD implantation.10-13 For the HM-
II LVAD, the relatively larger pump volume and surgical
creation of a pump pocket have limited the development of
minimally invasive techniques; however, several groups have
reported successful attempts at thoracotomy and diaphrag-
matic approaches, including implantation strategies per-
formed without cardiopulmonary bypass (“off pump”).7,9,14
In this illustrated review, we present the surgical principles
and techniques related to implantation of new-generation
CF-LVADs using alternative and less invasive approaches
(Figures 1-13).
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Figure 1 Positioning for left thoracotomy implantation. To select patients with left thoracotomy implantation, we carefully review baseline pulmonary function test results
and noncontrast chest computed tomography scan to evaluate the physiological risks associated with a left thoracotomy and anatomical positioning of the ascending aorta
and great vessels. For patients with chronic obstructive lung disease, careful evaluation of the capacity of postoperative pulmonary recovery from a thoracotomy is assessed.
Generally, patients with an FEV1o 50% predicted on pulmonary function testing is considered high risk for pulmonary complications, such as difﬁculty weaning from
postoperative mechanical ventilation. For sternal-sparing intercostal outﬂow graft approaches, a right-sided curvature of the ascending aorta is preferable. In patients with
multiple previous proximal coronary artery bypasses, the length of the ascending aorta is assessed along with the patency of grafts on preoperative angiogram and balanced
with the challenges of a less invasive approach for LVAD outﬂow graft anastomosis. All patients considered for minimally invasive and alternative approaches undergo
extensive multidisciplinary evaluation of preoperative transthoracic echocardiography (TTE) to assess chamber size, presence of signiﬁcant valve anomalies, right ventricular
(RV) size, and functional assessment,15 and the presence of LV thrombus. The TTE provides critical information to determine the need for concomitant surgical procedures
such as aortic or tricuspid valve repair or patent foramen ovale (PFO) closure at the time of LVAD implantation. Patients with more than mild aortic insufﬁciency (AI),
previous mechanical aortic valve replacement, more than moderate tricuspid regurgitation, and greater than moderate mitral stenosis are preferably approached through a
standard midline sternotomy incision. For patients with a documented preoperative LV thrombus, a midline sternotomy incision is preferred to clearly visualize the LV apex.
We generally do not close a PFO unless intraoperative transthoracic esophageal echocardiography (TEE) suggests clinical or hemodynamic signiﬁcance after implant. If
deemed signiﬁcant, percutaneous closure of the PFO using an Amplatzer occluding device is used. Preoperative imaging with computed tomography and vascular
ultrasound studies can identify patients who have severe aortic root calciﬁcation, abdominal or descending aortic aneurysm, or peripheral vascular disease, which facilitates
planning for outﬂow graft anastomosis and peripheral cannulation site for cardiopulmonary bypass. FEV ¼ forced expiratory volume.
Operative Technique
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Figure 2 Evaluation of left thoracotomy intercostal space. An intraoperative transthoracic echocardiogram is performed immediately before
proceeding with thoracotomy to identify the appropriate area for the thoracotomy incision. Generally, for larger, dilated ventricles, the
thoracotomy incision tends to be lateral, whereas patients with smaller left ventricular cavities need a more medial and anterior thoracotomy.
The thoracotomy incision is therefore performed and tailored to the individual patient based on the degree of LV remodeling. Transthoracic
echocardiography is performed by the operating surgeon and ensures appropriate thoracotomy positioning over the LV apex at the time of
surgery. Generally, the thoracotomy is performed in the ﬁfth of sixth intercostal space.
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Figure 3 Coring in patients with HVAD implantation. In patients with left thoracotomy implantation, the inﬂow ring placement is critical to
allow an easy pump placement. The locking pin mechanism has to be oriented toward the ceiling or pointing toward the anterior portion of
the incision to provide easy placement of the torque wrench through the left thoracotomy incision. Alternatively, a counter incision can be
performed anteriorly to tunnel the wrench and reach the inﬂow ring. Following heparin administration and initiation of cardiopulmonary
bypass, the coring knife is inserted in the LV apex. After coring is initiated, a direct LV intracavitary examination is thoroughly conducted to
inspect for thrombus or potential obstruction of the pump inﬂow. Indirect examination for LV thrombus is concurrently performed by
intraoperative TEE. For off-pump implantation, coring is performed after 30 mg of adenosine is given to induce bradycardic arrest. When the
coring knife is inserted, time is allowed for hemodynamic recuperation, and placement of the device assures an adequate seal of the LV cavity.
Following a second dose of 30 mg of adenosine, the HVAD pump is inserted and locked to its ﬁnal position. TEE ¼ transthoracic esophageal
echocardiography.
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Figure 4 HVAD placement. The HVAD pump is inserted through the left thoracotomy and locked into its ﬁnal position. For patients with
primary interventions, the outﬂow graft is gently looped within the pericardium to reach the ascending aorta. Half of the strain relief length is
generally removed before insertion to allow easier outﬂow graft placement and to allow better angulation of the outﬂow graft within the
pericardium. A dental mirror is used to evaluate proper pump placement and to ensure an adequate seal of the pump onto the inﬂow ring.
The driveline can be tunneled to the left subcostal area, but we prefer a right-sided tunneling using a midline subxiphoid counter incision.
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Figure 5 HeartMate II left thoracotomy implant. Using surface TTE, a 6-cm left anterior thoracotomy is performed to expose the LV apex.
Cardiopulmonary bypass is initiated using femoral access, and coring is performed under TEE guidance. The pump sewing ring is secured in
place facing the mitral valve. We use a tie wrap to secure the pump into position ﬁrst and use the provided stitch secondarily to secure the
pump in position. Two anchor stitches are kept out of the thoracotomy incision to facilitate countertraction for pump placement. This helps
secure the pump in optimal position while insertion is performed with a decompressed LV. TEE ¼ transthoracic esophageal
echocardiography.
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Figure 6 HeartMate II inﬂow cannula placement using left thoracotomy. The HeartMate II pump inﬂow cannula is inserted in the LV with the
pump pointing outside the thoracotomy incision to ease the insertion. A vent is generally used during this maneuver. The pump is locked into
position with the provided silk tie, and a tie wrap is applied to secure the pump in place. After proper placement of the pump, the body is
placed into the previously created supradiaphragmatic pump pocket. The outﬂow graft is then ﬁlled with saline and tunneled to the ascending
aorta through the thoracotomy incision. For patients with complete sternal-sparing approaches, the outﬂow graft is tunneled in the right
pleural cavity through a separate second right intercostal incision; however, an upper hemisternotomy can also be used.
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Figure 7 Sternal-sparing left thoracotomy HeartMate II implantation. Minimally invasive access for Heartmate II LVAD implant is technically
more challenging as the larger design of the pump requires creation of a pump pocket for appropriate pump placement. Our strategy for
minimally invasive implants uses a 4-cm subxiphoid incision to allow the creation of a large pump pocket. The abdominal rectus transversalis
fascia is opened and dissected laterally to create a plane above the preperitoneal fat. The dissection is further extended laterally on the left by
dividing diaphragmatic attachments and extending the created space to the left pleural cavity. For outﬂow graft placement to the ascending
aorta, we generally use a second incision over the right second intercostal space to ensure optimal surgical visualization and hemostasis during
anastomosis. A 20-mm ringed GORE-TEX graft is slid over the outﬂow graft before the end-to-side anastomosis to the ascending aorta. To
avoid infection, the driveline and outﬂow graft are ﬁnally carefully buried below the abdominal rectus transversalis fascia before closure of the
subxiphoid incision.
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Figure 8 Outﬂow graft anastomosis to the ascending aorta using upper hemisternotomy (both devices). Our most commonly used on-pump
minimally invasive strategy involves a less invasive modiﬁed approach as already described by Schmitto et al.5 Similarly, a 6-cm left anterior
thoracotomy is combined with a 4-cm right upper hemisternotomy for outﬂow graft placement. Cardiopulmonary bypass is established after
off-pump placement of the LV apex sewing ring and tunneling of the driveline to the right upper quadrant has been performed (using a 1-cm
counter substernal midline incision). For most patients, the outﬂow graft is tunneled within the pericardium and anastomosed on-pump, end-
to-side to the proximal ascending aorta using a partial cross-clamp. For patients who underwent a previous sternotomy, the HVAD outﬂow
graft is connected to the ascending aorta after tunneling the graft through the anterior mediastinum.
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Figure 9 Preparation of left axillary artery for outﬂow graft anastomosis after HVAD placement. The left axillary artery is exposed, and proximal
and distal control is obtained. Vessels loops are carefully passed around the axillary artery to allow better exposure. An 8-mm GORE-TEX
HEMASHIELD graft is anastomosed end-to-side to the proximal portion of the artery.
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Figure 10 Left thoracotomy to left axillary artery HVAD implantation. A left axillary outﬂow graft anastomosis has been increasingly used for
speciﬁc patient situations when outﬂow graft anastomosis to the ascending or the descending aorta is contraindicated (aortic aneurysm and
severe calciﬁcation). Despite the theoretical risk associated with increased left arm perfusion and subsequent arm hyperemia, this technique
represents a valuable option for this high-risk group of patients. We carefully administer 5000 units of heparin during left axillary artery
dissection and mobilization of vessels to minimize risks of thromboembolic complications. An 8-mm GORE-TEX HEMASHIELD graft is
beveled and anastomosed end-to-side to the proximal left axillary artery. The anastomosis has to be large and pointed toward the descending
aorta to minimize left arm hyperperfusion.
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Figure 11 End-to-end anastomosis of outﬂow graft for left axillary HVAD implantation. The (standard 10 mm) HVAD outﬂow graft is replaced
by a 10-mm ringed GORE-TEX HEMASHIELD graft. The ringed reinforcement of the outﬂow graft decreases risks of ﬂow restriction with arm
movement as it exits through the second intercostal space. A left thoracotomy off-pump strategy is generally preferred to minimize risks
associated with cardiopulmonary bypass in this high-risk population. The outﬂow graft is oriented to the left axillary artery and exits outside
the thoracic cavity through the second intercostal space. A beveled end-to-end anastomosis is then performed between the 10-mm ringed
outﬂow graft and the previously created 8-mm graft anastomosis.
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Figure 12 Distal restriction of left axillary artery after HVAD implantation. After the HVAD pump is deaired and started, the ﬂow is restricted in
the distal left axillary artery using a partial banding technique. Umbilical tape is passed around the left axillary artery and progressively
constricted to reduce the mean arterial pressure in the left arm to 50 mm Hg. It is noteworthy that it is critical to prepare the patient with
bilateral radial artery catheters before the intervention to assure monitoring after ligation and throughout the intervention. Partial ligation
reduces the risk of left arm hyperperfusion, while maintaining adequate arm blood ﬂow. After the pump is started and speed adjusted from
2300-2400 rpm, partial left axillary artery ligation is performed to decrease left arm perfusion. We found that a progressive step-by-step
increase in pump speed over a few days may allow gradual distal adaptation to the increased pump ﬂow and decrease risks of left arm
hyperperfusion.
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Figure 13 Descending aorta anastomosis using left thoracotomy for HVAD implant. We use a double-lumen intubation strategy to facilitate
lung retraction. The femoral vessels are exposed for cardiopulmonary bypass if needed. Lung adhesions are dissected if needed, and the
inferior pulmonary ligament is freed to optimize exposure. The patient is heparinized, the femoral vessels are cannulated, and
cardiopulmonary bypass (CPB) is initiated. The HVAD sewing ring position is conﬁrmed with TEE, and the apical sewing ring portion of the
HVAD inﬂow is secured in place using Ethibond 2-0 sutures with felts. After coring the LV, the HVAD is secured in place. The outﬂow graft is
measured and deaired, and a loop is deliberately created to bury the outﬂow graft in the left pulmonary ﬁssure creating a gentle loop to the
descending aorta. An off-pump end-to-side anastomosis using a HeartPort-assisted technique is performed on the descending aorta using a
partial cross-clamp, close to the vicinity of the junction of the diaphragm. The outﬂow graft anastomosis to the descending aorta is performed
through the same anterolateral thoracotomy and usually does not require a posterior extension of the incision. The driveline is tunneled, in
standard fashion, on the right using a subxiphoid counter incision. Alternatively, the aortic anastomosis can be performed ﬁrst before
placement of pump inﬂow. We found the latter approach to be more technically challenging. TEE ¼ transthoracic esophageal
echocardiography.
Nonsternotomy approaches for LVAD placement 289
S. Maltais et al.290OFF-Pump Implant
Considerations
Rapid ventricular pacing has been used to temporarily reduce
left ventricular (LV) ejection during off-pump LVAD inser-
tion.10,16 Our technique involves administration of an intra-
venous bolus of 30 mg of adenosine to induce a transient
bradycardic arrest during off-pump LVAD placement.
Adenosine-induced asystole renders the left ventricle immobile,
making it less technically challenging for the surgeon to place
the inﬂow cannula in the optimal anatomical LV apical
position. Transient bradycardic arrest decreases blood loss by
reducing both the volume of blood ejected from the heart
during LVAD implant (reduction in blood pressure) and
increasing time between heart beats. We have further observed
that an additional beneﬁt of this method was adenosine-
mediated pulmonary vasodilatation, which may reduce
pulmonary pressures and protect right ventricular function.17,18
Lastly, adenosine has an extremely limited half-life, which
minimizes the duration and potential deleterious hemodynamic
effects of asystole induction.19,20 As most patients with HF have
permanent pacemakers, it is important to set a low back up rate
preoperatively to achieve desired bradycardia intraoperatively.
Postoperative Management of
Patients With Partial Flow
Support
Despite demonstration of similar ﬂow patterns in patients with
descending aortic anastomosis, we believe that approaches
using outﬂow graft placement to the descending aorta or the
axillary artery represent a unique partial ﬂow situation, where
the ﬁnal cardiac output is a combination of native heart ejection
and pump contribution. It is critical to adjust the pump speed
to leave some aortic valve opening to allow aortic root washout
and to decrease the chance of stagnant blood and subsequent
clot formation. We recommend adjusting the pump speed to
provide adequate LV unloading as evidenced by improvement
in end-organ function, however still allow native heart ejection
and antegrade ﬂow across the aortic valve to minimize the risk
of thromboembolic complications.
Patients are typically extubated within 24 hours after surgery
in the cardiovascular intensive care unit. Postoperative anti-
coagulation and antiplatelet therapy is protocol driven
according to device type. Aspirin 325 mg (enteric coated) is
given daily beginning on postoperative day (POD) 1 for both
the devices. For HM-II devices only, dipyridamole 75 mg,
4 times daily, in addition to aspirin is administered beginning
on POD 1 for 1 month. Coumadin (international normalized
ratio (INR) goal: 2.0-3.0) is initiated beginning on POD 2 for
both devices. Postoperative heparin infusions are not used
unless INR goal is not reached on POD 5. Goal-directed
medical therapy for end-stage HF is added postoperatively
according to the national guidelines.21,22Pump Exchange Using a Left
Thoracotomy Approach
The incidence of patients with acute pump thrombosis has
recently increased, and the medical and surgical manage-ment of this patient population remains challenging.23 We
have found that a left thoracotomy approach can be valuable
to address patients with HVAD pump thrombosis. A left
anterior thoracotomy approach can be used for pump
exchange to spare complications associated with repeated
and possibly emergent sternal reentry. When outﬂow graft
and inﬂow positions are conﬁrmed to be free of thrombosis
or defect, the HVAD pump can be simply exchanged and the
outﬂow graft reconnected to the previously implanted
outﬂow graft using an end-to-end anastomosis. We prefer
tunneling the new driveline to the contralateral side (most
often left) to minimize risk of infection. Alternative incisions
for pump exchanges are effective and minimize the number
of sternotomies in patients listed for heart transplantation.Conclusions
Minimally invasive and alternative surgical techniques for
long-term contemporary LVAD placement are technically
feasible and reproducible with contemporary HVAD and
HM-II devices. We believe that ongoing surgical implant
innovations occurring at the bench and bedside, fueled by
collaborative discussions between high-volume institutions
and research partnerships with device companies, will
continue to develop novel surgical options for CF-LVAD
implantation.
Less surgically invasive approaches also promise the
possibility of increasing the number of high-risk surgical
patients who could beneﬁt from CF-LVAD therapies.
Further large collaborative and randomized studies are
needed to clarify the potential advantages and disadvantages
of these novel techniques on CF-LVAD patient outcomes.
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